HIVID 0.375 Pill - pink oval
Generic Name: zalcitabine
Pill with imprint HIVID 0.375 is Pink, Oval and has been identified as Hivid 0.375 MG. It is supplied by Roche Laboratories.
Hivid is used in the treatment of HIV Infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Hivid 0.375 MG is not a controlled substance under the Controlled Substances Act (CSA).
Images for HIVID 0.375
Hivid
- Generic Name
- zalcitabine
- Imprint
- HIVID 0.375
- Strength
- 0.375 MG
- Color
- Pink
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Roche Laboratories
- National Drug Code (NDC)
- 00004-0220 (Discontinued)
See also:
Biktarvy
Biktarvy is a complete HIV-1 treatment in a once-a-day single tablet containing three antiviral ...
Descovy
Descovy is used to treat and prevent HIV infection in adults and adolescents. When used for HIV-1 ...
Cabenuva
Cabenuva (cabotegravir and rilpivirine) injections are a long-acting HIV treatment used to keep HIV ...
Truvada
Truvada is used to prevent HIV (HIV PrEP) or treat HIV-1 infection in combination with other HIV-1 ...
Atripla
Atripla prevents the human immunodeficiency virus (HIV) from reproducing in your body. Learn about ...
Complera
Complera (emtricitabine, rilpivirine, and tenofovir) is used to treat HIV infection. Includes ...
Stribild
Stribild (cobicistat, elvitegravir, emtricitabine and tenofovir) is used to treat HIV-1 infection ...
Epzicom
Epzicom is used to treat HIV, which causes the acquired immunodeficiency syndrome (AIDS). Learn ...
Emtricitabine
Emtricitabine is used for HIV Infection, nonoccupational exposure, occupational exposure
More about Hivid (zalcitabine)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.